UB’s Summer Research Fellowship Program, which provides first-year medical students with a personalized experience in research, has been renewed through another five years of funding from the National Institutes of Health.
In the fight against infectious disease, University at Buffalo immunologist Michael W. Russell, PhD, professor of microbiology and immunology, advocates a novel alternative to antibiotics and vaccines: directly target the immune system.
University at Buffalo scientists will continue nearly three decades of groundbreaking research on a bacterium considered a key cause of the hallmark signs of chronic obstructive pulmonary disease (COPD).
With the ultimate goal of designing new immunotherapeutic strategies, Richard B. Bankert, VMD, PhD, professor of microbiology and immunology, and his team are working to re-activate cancer-killing T cells in a tumor’s microenvironment.
Richard B. Bankert, VMD, PhD, professor in the Department of Microbiology and Immunology, and Zhen Yan, PhD, professor in the Department of Physiology and Biophysics, have received 2013 SUNY Chancellor’s Awards for Excellence.
Innovations developed at least in part by faculty at UB’s School of Medicine and Biomedical Sciences accounted for nearly 40 percent of the provisional patent applications filed by the university in 2012.
UB researchers will use a $1.6 million grant from the National Institutes of Health to develop the first vaccine against an understudied bacterium that causes at least 10 percent of middle ear infections in children.